Clinical Trial Update: The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial assesses the efficacy of 10-day versus 14-day bismuth-containing quadruple therapy for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth-containing quadruple therapy

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN